Abstract
Background
Both of prolonged QT interval and elevated C-reactive protein (CRP) levels are known to be risk factors of cardiovascular disease. To our knowledge, few studies have reported the direct relationship between CRP levels and the QT interval in middle-aged population. The objective of the present study was to examine the association of CRP level with QT interval.
Methods and results
A total of 2471 men and 2287 women from the Korea n Health and Genome study underwent physical examination and completed a questionnaire. A 12-lead electrocardiogram (ECG) recording was obtained from each subject. Subjects who were taking statins, non-steroidal anti-inflammatory drugs (NSAID) and postmenopausal hormone replacement therapy, which are known to have an effect on CRP levels, were excluded. Geometric means of CRP levels were compared among three groups, which were classified by heart rate-corrected QT (QTc) interval: prolonged (≥440 msec in men and ≥450 msec in women), borderline (420–439 msec in men and 430–449 msec in women) and normal (<420 msec in men and <430 msec in women) groups. The means of CRP level in women, though over normal range, increased significantly as QTc interval was longer, independent of confounding factors, while those of men were on the borderline of significance. However, compared to normal range of QTc interval, prolonged QTc interval was associated with elevated CRP level, defined as more than 95 percentile of CRP, in men and women, respectively.
Conclusions
Prolonged QTc interval in middle-aged men and women is associated with the elevated CRP, independent of confounding factors.
Similar content being viewed by others
Abbreviations
- BMI:
-
body-mass index
- CRP:
-
C-reactive protein
- ECG:
-
electrocardiogram
- HDL:
-
high-density lipoprotein
- NSAID:
-
non-steroidal anti-inflammatory drug
- QTc:
-
heart rate-corrected QT
Reference
Lepeschkin E, Surawicz B (1952). Measurement of the QT interval of the electrocardiogram. Circulation 6:378–388
Tan HL, Hou CJ, Lauer MR, Sung RJ (1995) Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 122:701–714
Moss AJ (1993). Measurement of the QT interval and the risk associated with QTc interval prolongation: A review. Am J Cardiol 72:23B–25B
Schwartz PJ, Wolf S (1978). QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 57:1074–1077
Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR (2004). Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: The ARIC study. J Am Coll Cardiol 43:565–571
Robbins J, Nelson JC, Rautaharju PM, Gottdiener JS (2003). The association between the length of the QT interval and mortality in the Cardiovascular Health Study. Am J Med 115:689–694
Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J (1991). QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84:1516–1523
Busjahn A, Knoblauch H, Faulhaber HD, et al. (1999) QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation 99:3161–3164
Woosley RL, Sale M (1993). QT interval: A measure of drug action. Am J Cardiol 72:36B–43B
Ahnve S, Vallin H (1982). Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation 65:435–439
Magnano AR, Holleran S, Ramakrishnan R, Reiffel JA, Bloomfield DM (2002). Autonomic nervous system influences on QT interval in normal subjects. J Am Coll Cardiol 39:1820–1826
Nakagawa M, Ooie T, Ou B, et al. (2005) Gender differences in autonomic modulation of ventricular repolarization in humans. J Cardiovasc Electrophysiol 16:278–284
Bellavere F, Ferri M, Guarini L, et al. (1988) Prolonged QT period in diabetic autonomic neuropathy: A possible role in sudden cardiac death?. Br Heart J 59:379–383
Glickstein JS, Schwartzman D, Friedman D, Rutkowski M, Axelrod FB (1993). Abnormalities of the corrected QT interval in familial dysautonomia: An indicator of autonomic dysfunction. J Pediatr 122:925–928
Diedrich A, Jordan J, Shannon JR, Robertson D, Biaggioni I (2002). Modulation of QT interval during autonomic nervous system blockade in humans. Circulation 106:2238–2243
Du Clos TW (2000). Function of C-reactive protein. Ann Med 32:274–278
Gabay C, Kushner I (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454
Danesh J, Wheeler JG, Hirschfield GM, et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397
Koenig W, Sund M, Frohlich M, et al. (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237–242
Tracy RP, Lemaitre RN, Psaty BM, et al. (1997) Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17:1121–1128
Pearson TA, Mensah GA, Alexander RW, et al. (2003) Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499–511
Borovikova LV, Ivanova S, Zhang M, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458–462
Tracey KJ (2002). The inflammatory reflex. Nature 420:853–859
Janszky I, Ericson M, Lekander M, et al. (2004) Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 256:421–428
Malave HA, Taylor AA, Nattama J, Deswal A, Mann DL (2003). Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: A study in patients with mild-to-moderate heart failure. Chest 123:716–724
Kazumi T, Kawaguchi A, Hirano T, Yoshino G (2003). C-reactive protein in young, apparently healthy men: Associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism 52:1113–1116
Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF (2004). Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 25:363–370
Shin C, Abbott RD, Lee H, Kim J, Kimm K (2004). Prevalence and correlates of orthostatic hypotension in middle-aged men and women in Korea: The Korean Health and Genome Study. J Hum Hypertens 18:717–723
Shin C, Lee S, Abbott RD, et al. (2004) Respiratory symptoms and undiagnosed airflow obstruction in middle-aged adults: The Korean Health and Genome Study. Chest 126:1234–1240
Albert MA, Danielson E, Rifai N, Ridker PM (2001). Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA 286:64–70
Kluft C, Leuven JA, Helmerhorst FM, Krans HM (2002). Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment. Vascul Pharmacol 39:149–154
Laiho K, Belt E, Maenpaa H, Kautiainen H, Kauppi M (2001). Effect of daily corticosteroid treatment on CRP response to hip or knee replacement in patients with RA. Ann Rheum Dis 60:989
Bazett H (1920). An analysis of time relations of the electrocardiograms. Heart 7:353–367
WHO (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163
Alberti KG, Zimmet PZ (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539–553
Chobanian AV, Bakris GL, Black HR, et al. (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206–1252
Macfarlane PW (2000). Minnesota coding and the prevalence of ECG abnormalities. Heart 84:582–584
Lane PW, Nelder JA (1982). Analysis of covariance and standardization as instances of prediction. Biometrics 38:613–621
Roden DM, Spooner PM (1999). Inherited long QT syndromes: A paradigm for understanding arrhythmogenesis. J Cardiovasc Electrophysiol 10:1664–1683
Roden DM (2004). Drug-induced prolongation of the QT interval. N Engl J Med 350:1013–1022
Peters RW, Byington RP, Barker A, Yusuf S (1990). Prognostic value of prolonged ventricular repolarization following myocardial infarction: The BHAT experience. The BHAT Study Group. J Clin Epidemiol 43:167–172
Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB (2001). Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk 8:227–233
Dekker JM, Feskens EJ, Schouten EG, Klootwijk P, Pool J, Kromhout D (1996). QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study. Diabetes 45:376–380
Gastaldelli A, Emdin M, Conforti F, Camastra S, Ferrannini E (2000). Insulin prolongs the QTc interval in humans. Am J Physiol Regul Integr Comp Physiol 279:R2022–R2025
Carella MJ, Mantz SL, Rovner DR, et al. (1996) Obesity, adiposity, and lengthening of the QT interval: Improvement after weight loss. Int J Obes Relat Metab Disord 20:938–942
Madden K (2001). Catecholamines, sympathetic nerves and immunity. In: Ader R, Felten D, Cohen N, (eds) Psychoneuroimmunology 3rd ed. New York, Academic Press, pp. 197–216
Aronson D, Mittleman MA, Burger AJ (2001). Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 12:294–300
Jensen-Urstad M, Jensen-Urstad K, Ericson M, Johansson J (1998). Heart rate variability is related to leucocyte count in men and to blood lipoproteins in women in a healthy population of 35-year-old subjects. J Intern Med 243:33–40
Goldman MJ. Principles of Clinical Electrocardiography, 8th edn. In: Los Altos (ed), Lange Medical Publications, California 1973: 24–28
Lepeschkin E. Mordern Electrocardiography. Vol. 1. Williams and Wilkins, Baltimore, MD, 1951
Acknowledgements
This study was supported by Center for Genome Science, Korea National Institute of Health, (Budgets 2001-347-6111-221 and 2002-347-6111-221).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, E., Joo, S., Kim, J. et al. Association between C-reactive protein and QTc interval in middle-aged men and women. Eur J Epidemiol 21, 653–659 (2006). https://doi.org/10.1007/s10654-006-9034-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-006-9034-9